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Hypertensive left ventricular hypertrophy(LVH) is associated with altered left
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We have shown that mutant cardiac j3-myosin is present in slow skeletal mus-
cle from patients with hypertrophic cardiomyopathy (HeM) caused by the
403Arg_Gln j3-myosin heavy chain (j3-MHC) gene mutation. Slow myofibers
with this mutation have impaired maximal isometric tension and shortening
velocity. This study examines whether ultrastructural changes account for the
altered contractile properties. Single soleus muscle fibers from 4 patients
(two unrelated kind reds) with the 403Arg_Gln mutation and 3 normal con-
trols, were chemically permeabilized, and mounted under a light microscope
at a length 10% longer than the slack length to measure sarcomeric spac-
ing. Electronmicroscopy was used to evaluate sarcomeric structure of fixed
fibers, as well as to measure the length of thick filaments obtained from elas-
tase digestion of other fibers. Although sarcomeric structure was normal, the
sarcomeric spacing was "'20% shorter compared with normal controls (1.70
versus 2.10 JLm). The isolated thick filaments were also "'20% shorter com-
pared to the normal controls: 1.25 ± 0.14 JLm (n = 248) versus 1.55 ± 0.07
JLm (n ~ 1891, P < 0.001. This reduction of thick filament length and con-
comitant decrease in myosin heads, will (1) reduce the isometric force per
cross-sectional area compared to fibers with normal length, and (2) increase
the maximal shortening velocity as there will be more sarcomeres per unit
length of muscle fiber. This observation suggests that in HCM caused by this
j3-MHC mutation, there is a pathway linking changes in the molecular motor
to alterations in sarcomeric ultrastructure.
Regression of LVH in SHR with Iisinopril treatment was associated with
significantly increased hydroxyproline per unit weight of tissue, protein and
DNA. Selective regression of cardiac proteins with lisinopril may have impor-
tant function implications.
ventricular (LV) filling; this may persist despite regression of LVH with treat-
ment. Collagen occupies about 3% of the LV mass and contributes to my-
ocardial stiffness. Collagen content may be assessed experimentally by as-
say of hydroxyproline, an amino acid virtually unique to collagen. The effects
of lisinopril treatment on LV hydroxyproline content were studied in 15 week
old spontaneously hypertensive rats (SHR) and 15 week old normotensive
Wistar Kyoto rats (WKY). Rats were treated with lisinopril (LIS) in water (5
mglkg/day) for 8 weeks. Control rats were given plain tap water. LV hydrox-
yproline content was assayed by a spectrophotometric method after sacri-
fice. LIS lowered blood pressure (BP) in SHR significantly; BP in WKY was
unaltered. LV mass was significantly greater in SHR controls than WKY con-
trols (1062 ± 40 mg vs 896 ± 9.4 mg, p < 0.01). LV mass regressed with LIS
in both SHR (1062 ± 40 vs 786 ± 18.3 mg, p < 0.001) and WKY (896 ± 9.4
vs 760 ± 33.1 mg, p < 0.01). Hydroxyproline levels were significantly higher
in treated SHR than controls: no difference was seen between treated and
control WKY.
Impaired coronary blood flow reserve and myocardial ischemia in the ab-
sence of epicardial coronary artery disease is a frequent and important patho-
physiologic feature of hypertrophic cardiomyopathy (HCM). To provide the
morphologic basis for such findings, we studied the hearts of 16 pts with
HCM (ages 11-31 yrs; mean 20) who had died suddenly. Transmural sec-
tions of ventricular septum were studied (area 5.2 ± 2 cm2) after staining with
picrosirius-red; 9 ± 2 abnormal intramural coronary arteries (IMCAs)were an-
alyzed per section. Compared to 16 structurally normal control hearts, IMCAs
in HCM had substantially greater (12-fold) collagen volume fraction in media
(2.5 ± 2-vs-0.2 ± 0.3%, p < 0.01). as well as larger outer diameter (120 ±
46-vs-82 ± 22 JLm, p < 0.01). luminal diameter (88 ± 33-vs-62 ± 19 JLm, p <
0.05), medial thickness (32 ± 20-vs-20 ± 6 JLm, p < 0.05) and also perivascular
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thrombin time at a concentration of 23 nmol~ and the activated partial throm-
boplastin time (APTT) at 1.1 JLmol~. Thrombin induced platelet aggregation is
inhibited at an IC50 of 17 nmol~. Inogatran was studied in healthy male hu-
man volunteers with regard to tolerability. pharmacokinetics and effects on
haemostasis. It was given intravenously as a bolus in doses from 0.002 to
1.1 JLmollkg (n = 2-4 at each dose). The highest peak plasma concentration
observed was 7 JLmol~, corresponding to an APTT prolongation of 3 times.
The drug was also given as a constant infusion over 4 h at a dose of 0.73
JLmollkg per h (n = 16) which resulted in a mean plasma concentration at
steady state of 1.9 JLmolll and an APTT prolongation of 2.3 times. Finally, it
was given as a bolus with radiolabeled compound in a total dose of 25 JLmol
(n = 16). The drug was well tolerated and without side effects with the excep-
tion of slightly increased bleeding tendency at the blood sampling site. Ino-
gatran had avolume of distribution of 0.26 mllkg and a total plasma clearance
of 6.1 mllmin per kg, resulting in a half life of about one hour. The drug was
not metabolised and it was excreted unchanged with the elimination evenly
distributed between urine and faeces. Ex vivo the thrombin time was linearly
correlated to the plasma concentration while the APTT-concentration curve
was non-linear. At the highest plasma concentrations a slight prolongation
of the capillary bleeding time was seen in some subjects. Markers of throm-
bin activity (thrombin-antithrombin complex and prothrombin fragments 1-2)
decreased during the constant infusion of the drug. There was no effect on
fibrinolysis (PAI-l and t-PA activities) or protein C. It is concluded that inoga-
tran is a safe and effective anticoagulant with favourable pharmacokinetics
for Lv. use.
We have characterised the age-related changes of contractility and j3-
adrenoceptorfunction in isolated cardiac myocytes from guinea-pigs. Pertus-
sis toxin treatment was used to determine the contribution of Gi effects to the
change in sensitivity to j3-adrenoceptor stimulation. Myocytes were isolated
from either adult animals from 2 weeks to 14 week of age, where bodyweight
increases linearly with age, or senescent ones aged between 53-65 weeks.
There was some indication of a decrease in contractility in maximum Ca2+
with age, with significant differences between a young (::04 weeks, weight
< 400 g) and aged (::.:8 weeks, weight> 600 g) group in contraction ampli-
tude (% shortening) or contraction and relaxation velocities. This decline was
continued into senescence, and ANOVA showed a significant difference be-
tween the three groups for percentage shortening (12.2 ± 0.9%, young, n =
31; 9.5 ± 0.6%, n = 28 aged; 6.7 ± 0.8%, n = 6, senescent; P = 0.005). and
contraction or relaxation velocities (P < 0.001). There was a more pronounced
decline with age for maximum contraction amplitude in isoproterenol (11.8 ±
0.7%. n = 30, young; 7.9 ± 0.5%, n = 28, aged and 5.5 ± 1.1 %, n = 6, senes-
cent; P < 0.001) and the isoproterenollCa2+ ratio was reduced (P < 002). The
EC50 value for isoproterenol was similar in young (1.7 ± 0.4 nM) and aged
(1.6 ± 0.8 nM) animals, but significantly higher in senescent (16.8 ± 6 nM) (P
< 0.05. ANOVA). Pertussis toxin treatment decreased the EC50 in all groups,
but the effect was most pronounced for senescent animals. The final EC50
values in toxin-treated cells were 0.22 ± 0.11 nM (young), 0.19 ± 0.08 nM
(aged) and 0.12 ± 0.01 nM (senescent): these were not significantly differ-
ent. A general decrease in contractility of the myocyte occurs as the animal
ages, but the effect is more pronounced for j3-adrenoceptor stimulation than
for high Ca2+, consistent with a specific lesion in the adenylate cyclase re-
lated pathway. The ability of pertussis treatment to equalise EC50 values for
isoproterenol between the groups suggests that an increase in activity of Gi
contributes to the reduced j3-adrenoceptor sensitivity in senescent animals.
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